Erythropoietin biosimilar (Klarvoyant Biogenics)
促红细胞生成素生物类似药 (Klarvoyant Biogenics)
Report date: 2022/01/14 13:23:58
Base Information
Drug NameErythropoietin biosimilar (Klarvoyant Biogenics)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesKlarvoyant
China Registration ClassN/A
Develop Information
Other Information
ATC Code
Related LinksN/A